Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer

There is increasing interest in the use of cell-free circulating tumor DNA (ctDNA) as a serum marker for therapy assessment in prostate cancer patients. Prostate cancer is characterized by relatively low numbers of mutations, and, in contrast to many other common epithelial cancers, commercially ava...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dis Markers
Main Authors: Krumbholz, Manuela, Agaimy, Abbas, Stoehr, Robert, Burger, Maximilian, Wach, Sven, Taubert, Helge, Wullich, Bernd, Hartmann, Arndt, Metzler, Markus
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930771/
https://ncbi.nlm.nih.gov/pubmed/31915468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5085373
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados